James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 144,058 shares at $17.26 ($2.5M) on 2016-08-17, disclosed to the SEC on 2016-08-18.
Open-market purchase of $2.5M RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |